This piece is written by SCALE Co-Founder & CEO, Roy Bejarano, SCALE Co-Founder & President, Jason Schifman, and Columbia Business School MBA ’20 Candidate, Emma McGregor with expert contributions made from the SCALE team of Chief Advisors.
In the second piece in our COVID-19 series, our team of Scale healthcare management experts explore the topic of applying data to the crisis discussion. The point remains, where is the model that we are modifying and being educated on day in and day out?
SCALE believes deeply in developing systems to arrive at factual, statistically relevant data as quickly as possible. Having, and then using, actual data is critical. At the same time, we believe in the value of reserving room for alternative analysis and models based on interpretations and extrapolations of evolving circumstances.
In this whitepaper, we explore:
- Our current interpretation of the virus through data synthesis & analysis
- The role of a COVID-19 crisis response executive summary dashboard